Vault-13

Birchview Capital, LP

BURLINGTON, VT · CIK 1618205 · 13F filing filed 2023-08-08

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$133.4m reported value +4.5% vs Q1 2023
54positions
72.5%in top 10
1 new 8 added 3 reduced 2 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BRISTOL-MYERS SQUIBB CO COM BMY BMY 728,585 $46.6m34.92% 34.92% UnchangedShares held: Q3 2022 727.8k, Q4 2022 727.8k, Q1 2023 728.6k, Q2 2023 728.6k
2 PROTHENA CORP PLC SHS PRTA PRTA 156,111 $10.7m7.99% 7.99% AddedShares held: Q3 2022 118.9k, Q4 2022 127.2k, Q1 2023 128.4k, Q2 2023 156.1k +27.7k +27,716 21.6%
3 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 84,240 $7.9m5.95% 5.95% UnchangedShares held: Q3 2022 85.2k, Q4 2022 84.2k, Q1 2023 84.2k, Q2 2023 84.2k
4 BIODESIX INC COM COM 5,039,633 $6.2m4.65% 4.65% UnchangedShares held: Q3 2022 2.4m, Q4 2022 5.0m, Q1 2023 5.0m, Q2 2023 5.0m
5 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 249,400 $6.0m4.48% 4.48% UnchangedShares held: Q3 2022 249.4k, Q4 2022 249.4k, Q1 2023 249.4k, Q2 2023 249.4k
6 QUIDEL CORP COM QDEL QDEL 65,203 $5.4m4.05% 4.05% AddedShares held: Q3 2022 61.3k, Q4 2022 61.3k, Q1 2023 61.3k, Q2 2023 65.2k +3.9k +3,897 6.4%
7 ELUTIA INC CL A COM ELUT ELUT 1,655,184 $3.9m2.93% 2.93% UnchangedShares held: Q3 2022 1.4m, Q4 2022 1.5m, Q1 2023 1.7m, Q2 2023 1.7m
8 IMMUNOGEN INC COM IMGN IMGN 190,000 $3.6m2.69% 2.69% AddedShares held: Q3 2022 150.0k, Q4 2022 150.0k, Q1 2023 150.0k, Q2 2023 190.0k +40.0k +40,000 26.7%
9 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 15,000 $3.3m2.48% 2.48% UnchangedShares held: Q3 2022 15.0k, Q4 2022 15.0k, Q1 2023 15.0k, Q2 2023 15.0k
10 OVINTIV INC COM OVV OVV 84,200 $3.2m2.40% 2.40% UnchangedShares held: Q3 2022 84.2k, Q4 2022 84.2k, Q1 2023 84.2k, Q2 2023 84.2k
11 HARROW INC COM HROW HROW 150,000 $2.9m2.14% 2.14% ReducedShares held: Q3 2022 180.0k, Q4 2022 180.0k, Q1 2023 180.0k, Q2 2023 150.0k -30.0k -30,000 -16.7%
12 PHREESIA INC COM PHR PHR 82,700 $2.6m1.92% 1.92% UnchangedShares held: Q3 2022 82.7k, Q4 2022 82.7k, Q1 2023 82.7k, Q2 2023 82.7k
13 MASIMO CORP COM MASI MASI 15,280 $2.5m1.88% 1.88% UnchangedShares held: Q3 2022 15.3k, Q4 2022 15.3k, Q1 2023 15.3k, Q2 2023 15.3k
14 FOGHORN THERAPEUTICS INC COM FHTX FHTX 264,843 $1.9m1.40% 1.40% UnchangedShares held: Q3 2022 264.8k, Q4 2022 264.8k, Q1 2023 264.8k, Q2 2023 264.8k
15 INHIBRX INC COM INBX INBX 70,448 $1.8m1.37% 1.37% UnchangedShares held: Q3 2022 70.4k, Q4 2022 70.4k, Q1 2023 70.4k, Q2 2023 70.4k
16 ACCELERATE DIAGNOSTICS INC COM COM 2,252,388 $1.8m1.37% 1.37% UnchangedShares held: Q3 2022 2.3m, Q4 2022 2.3m, Q1 2023 2.3m, Q2 2023 2.3m
17 ALKERMES PLC SHS ALKS ALKS 50,000 $1.6m1.17% 1.17% UnchangedShares held: Q3 2022 50.0k, Q4 2022 50.0k, Q1 2023 50.0k, Q2 2023 50.0k
18 ALPHATEC HLDGS INC COM NEW ATEC ATEC 80,000 $1.4m1.08% 1.08% UnchangedShares held: Q3 2022 10.0k, Q4 2022 90.0k, Q1 2023 80.0k, Q2 2023 80.0k
19 EQUITRANS MIDSTREAM CORP COM ETRN ETRN 133,050 $1.3m0.95% 0.95% UnchangedShares held: Q3 2022 133.1k, Q4 2022 133.1k, Q1 2023 133.1k, Q2 2023 133.1k
20 CORCEPT THERAPEUTICS INC COM CORT CORT 50,000 $1.1m0.83% 0.83% UnchangedShares held: Q3 2022 50.0k, Q4 2022 50.0k, Q1 2023 50.0k, Q2 2023 50.0k
21 APELLIS PHARMACEUTICALS INC COM APLS APLS 12,000 $1.1m0.82% 0.82% UnchangedShares held: Q3 2022 12.0k, Q4 2022 12.0k, Q1 2023 12.0k, Q2 2023 12.0k
22 SOLENO THERAPEUTICS INC COM COM 245,127 $1.1m0.79% 0.79% UnchangedShares held: Q3 2022 245.1k, Q4 2022 245.1k, Q1 2023 245.1k, Q2 2023 245.1k
23 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 38,000 $1.0m0.79% 0.79% UnchangedShares held: Q3 2022 38.0k, Q4 2022 38.0k, Q1 2023 38.0k, Q2 2023 38.0k
24 DOCGO INC COM DCGO DCGO 110,000 $1.0m0.77% 0.77% UnchangedShares held: Q3 2022 110.0k, Q4 2022 110.0k, Q1 2023 110.0k, Q2 2023 110.0k
25 IVERIC BIO INC COM OPHT OPHT 25,000 $983.5k0.74% 0.74% UnchangedShares held: Q3 2022 25.0k, Q4 2022 25.0k, Q1 2023 25.0k, Q2 2023 25.0k
26 STOKE THERAPEUTICS INC COM STOK STOK 85,000 $903.5k0.68% 0.68% AddedShares held: Q3 2022 15.0k, Q4 2022 15.0k, Q1 2023 15.0k, Q2 2023 85.0k +70.0k +70,000 466.7%
27 VENTYX BIOSCIENCES INC COM VTYX VTYX 26,400 $865.9k0.65% 0.65% UnchangedShares held: Q3 2022 45.0k, Q4 2022 22.0k, Q1 2023 26.4k, Q2 2023 26.4k
28 BLUEBIRD BIO INC COM COM 249,200 $819.9k0.61% 0.61% AddedShares held: Q3 2022 98.0k, Q4 2022 98.0k, Q1 2023 199.2k, Q2 2023 249.2k +50.0k +50,000 25.1%
29 CYTOKINETICS INC COM NEW CYTK CYTK 25,000 $815.5k0.61% 0.61% UnchangedShares held: Q3 2022 25.0k, Q4 2022 25.0k, Q1 2023 25.0k, Q2 2023 25.0k
30 PIONEER NAT RES CO COM PXD PXD 3,800 $787.3k0.59% 0.59% UnchangedShares held: Q3 2022 3.8k, Q4 2022 3.8k, Q1 2023 3.8k, Q2 2023 3.8k
31 10X GENOMICS INC CL A COM TXG TXG 12,000 $670.1k0.50% 0.50% AddedShares held: Q3 2022 0, Q4 2022 10.0k, Q1 2023 10.0k, Q2 2023 12.0k +2.0k +2,000 20.0%
32 SILK RD MED INC COM SILK SILK 20,000 $649.8k0.49% 0.49% AddedShares held: Q3 2022 10.0k, Q4 2022 10.0k, Q1 2023 10.0k, Q2 2023 20.0k +10.0k +10,000 100.0%
33 TRAVERE THERAPEUTICS INC COM TVTX TVTX 40,000 $614.4k0.46% 0.46% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 30.0k, Q2 2023 40.0k +10.0k +10,000 33.3%
34 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 59,833 $605.5k0.45% 0.45% UnchangedShares held: Q3 2022 59.8k, Q4 2022 59.8k, Q1 2023 59.8k, Q2 2023 59.8k
35 CHINOOK THERAPEUTICS INC COM ADRO ADRO 15,000 $576.3k0.43% 0.43% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 15.0k, Q2 2023 15.0k
36 KARYOPHARM THERAPEUTICS INC COM COM 291,332 $521.5k0.39% 0.39% UnchangedShares held: Q3 2022 269.3k, Q4 2022 291.3k, Q1 2023 291.3k, Q2 2023 291.3k
37 KINIKSA PHARMACEUTICALS LTD COM CL A COM CL A 30,000 $422.4k0.32% 0.32% UnchangedShares held: Q3 2022 30.0k, Q4 2022 30.0k, Q1 2023 30.0k, Q2 2023 30.0k
38 XENON PHARMACEUTICALS INC COM XENE XENE 10,000 $385.0k0.29% 0.29% UnchangedShares held: Q3 2022 10.0k, Q4 2022 10.0k, Q1 2023 10.0k, Q2 2023 10.0k
39 ARVINAS INC COM ARVN ARVN 15,000 $372.3k0.28% 0.28% UnchangedShares held: Q3 2022 15.0k, Q4 2022 15.0k, Q1 2023 15.0k, Q2 2023 15.0k
40 AXOGEN INC COM AXGN AXGN 40,000 $365.2k0.27% 0.27% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 40.0k
41 HALOZYME THERAPEUTICS INC COM HALO HALO 10,000 $360.7k0.27% 0.27% UnchangedShares held: Q3 2022 0, Q4 2022 10.0k, Q1 2023 10.0k, Q2 2023 10.0k
42 KALVISTA PHARMACEUTICALS INC COM KALV KALV 40,000 $360.0k0.27% 0.27% UnchangedShares held: Q3 2022 40.0k, Q4 2022 40.0k, Q1 2023 40.0k, Q2 2023 40.0k
43 PROGYNY INC COM PGNY PGNY 9,000 $354.1k0.27% 0.27% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 9.0k, Q2 2023 9.0k
44 AMICUS THERAPEUTICS INC COM FOLD FOLD 28,000 $351.7k0.26% 0.26% UnchangedShares held: Q3 2022 38.0k, Q4 2022 28.0k, Q1 2023 28.0k, Q2 2023 28.0k
45 XENCOR INC COM XNCR XNCR 12,300 $307.1k0.23% 0.23% UnchangedShares held: Q3 2022 12.3k, Q4 2022 12.3k, Q1 2023 12.3k, Q2 2023 12.3k
46 SAREPTA THERAPEUTICS INC COM SRPT SRPT 2,500 $286.3k0.21% 0.21% UnchangedShares held: Q3 2022 2.5k, Q4 2022 2.5k, Q1 2023 2.5k, Q2 2023 2.5k
47 KEROS THERAPEUTICS INC COM KROS KROS 7,000 $281.3k0.21% 0.21% UnchangedShares held: Q3 2022 0, Q4 2022 7.0k, Q1 2023 7.0k, Q2 2023 7.0k
48 CULLINAN THERAPEUTICS INC COM CGEM CGEM 25,114 $270.2k0.20% 0.20% UnchangedShares held: Q3 2022 25.1k, Q4 2022 25.1k, Q1 2023 25.1k, Q2 2023 25.1k
49 INFLARX NV COM IFRX IFRX 50,000 $223.0k0.17% 0.17% ReducedShares held: Q3 2022 70.0k, Q4 2022 70.0k, Q1 2023 70.0k, Q2 2023 50.0k -20.0k -20,000 -28.6%
50 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 20,000 $140.8k0.11% 0.11% UnchangedShares held: Q3 2022 20.0k, Q4 2022 20.0k, Q1 2023 20.0k, Q2 2023 20.0k
51 GOSSAMER BIO INC COM GOSS GOSS 99,088 $118.9k0.09% 0.09% UnchangedShares held: Q3 2022 159.1k, Q4 2022 99.1k, Q1 2023 99.1k, Q2 2023 99.1k
52 G1 THERAPEUTICS INC COM GTHX GTHX 40,000 $99.6k0.07% 0.07% UnchangedShares held: Q3 2022 40.0k, Q4 2022 40.0k, Q1 2023 40.0k, Q2 2023 40.0k
53 YIELD10 BIOSCIENCE INC COM COM 18,750 $41.6k0.03% 0.03% UnchangedShares held: Q3 2022 18.8k, Q4 2022 18.8k, Q1 2023 18.8k, Q2 2023 18.8k
54 NEKTAR THERAPEUTICS COM COM 28,000 $16.1k0.01% 0.01% ReducedShares held: Q3 2022 128.0k, Q4 2022 118.0k, Q1 2023 118.0k, Q2 2023 28.0k -90.0k -90,000 -76.3%

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
ANGION BIOMEDICA CORP 54,392 $32.0k54.4k shares
ASPIRA WOMENS HEALTH INC 60,070 $22.0k60.1k shares